Jpmorgan Chase & CO Arcturus Therapeutics Holdings Inc. Transaction History

Jpmorgan Chase & CO

$1.22 Trillion
Q3 2024

A detailed history of Jpmorgan Chase & CO transactions in Arcturus Therapeutics Holdings Inc. stock. As of the latest transaction made, Jpmorgan Chase & CO holds 256,716 shares of ARCT stock, worth $4.15 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

256,716

Previous 272,007 5.62%

Holding current value

$4.15 Million

Previous $6.62 Million 10.04%

% of portfolio

0.0%

Previous 0.0%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 08, 2024	SELL	$18.08 - $25.38 $276,461 - $388,085	-15,291 Reduced 5.62%	256,716 $5.96 Million
Q2 2024 Aug 12, 2024	SELL	$24.35 - $44.39 $1.11 Million - $2.02 Million	-45,544 Reduced 14.34%	272,007 $6.62 Million
Q1 2024 May 10, 2024	SELL	$31.23 - $42.99 $164,519 - $226,471	-5,268 Reduced 1.63%	317,551 $10.7 Million
Q4 2023 Feb 12, 2024	SELL	$17.71 - $32.97 $85,539 - $159,245	-4,830 Reduced 1.47%	322,819 $10.2 Million
Q3 2023 Nov 14, 2023	SELL	$25.44 - $37.35 $276,609 - $406,106	-10,873 Reduced 3.21%	327,649 $8.37 Million
Q2 2023 Aug 11, 2023	SELL	$23.94 - $32.36 $79,432 - $107,370	-3,318 Reduced 0.97%	338,522 $9.71 Million
Q1 2023 May 18, 2023	BUY	$14.72 - $23.97 $260,617 - $424,388	17,705 Added 5.46%	341,840 $8.19 Million
Q1 2023 May 11, 2023	SELL	$14.72 - $23.97 $280,298 - $456,436	-19,042 Reduced 5.55%	324,135 $7.77 Million
Q4 2022 Feb 13, 2023	SELL	$14.14 - $23.06 $42,052 - $68,580	-2,974 Reduced 0.86%	343,177 $5.82 Million
Q3 2022 Nov 14, 2022	BUY	$13.05 - $22.13 $275,237 - $466,743	21,091 Added 6.49%	346,151 $5.13 Million
Q2 2022 Aug 11, 2022	SELL	$12.26 - $31.17 $919 - $2,337	-75 Reduced 0.02%	325,060 $5.12 Million
Q1 2022 May 11, 2022	SELL	$17.64 - $39.57 $519,356 - $1.17 Million	-29,442 Reduced 8.3%	325,135 $8.77 Million
Q4 2021 Feb 10, 2022	BUY	$34.2 - $47.56 $4.13 Million - $5.74 Million	120,744 Added 51.64%	354,577 $13.1 Million
Q3 2021 Nov 12, 2021	BUY	$27.88 - $58.25 $6.52 Million - $13.6 Million	233,833 New	233,833 $11.2 Million

Others Institutions Holding ARCT

# of Institutions

179

Shares Held

25.6M

Call Options Held

195K

Put Options Held

133K

View Full List

About Arcturus Therapeutics Holdings Inc.

Ticker ARCT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 26,576,400
Market Cap $430M
Description
Arcturus Therapeutics Holdings Inc., an RNA medicines company, focuses on the development of vaccines for infectious, and liver and respiratory rare diseases in the United States. The company's development programs comprise LUNAR-OTC development program for ornithine transcarbamylase (OTC) deficiency; and LUNAR-CF program for cystic fibrosis lun...

More about ARCT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

News

Stay updated on Jpmorgan Chase & CO with notifications on news.

Account

Jpmorgan Chase & CO Arcturus Therapeutics Holdings Inc. Transaction History